β3-Adrenoceptors in the cardiovascular system

Trends in Pharmacological Sciences

Volumn 21, Issue 11, 2000, Pages 426-431

  Gauthier, Chantal ^a   Langin, Dominique ^b   Balligand, Jean Luc ^c  

^a UNIVERSITÉ DE NANTES   (France)

^b CHU RANGUEIL   (France)

^c UNIVERSITY OF LOUVAIN MEDICAL SCHOOL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 ETHYLPHENOXY) 3 (1,2,3,4 TETRAHYDRO 1 NAPHTHYLAMINO) 2 PROPANOL OXALATE; 4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; 4 [2 [(2 HYDROXY 2 PHENYLETHYL)AMINO]ETHOXY]PHENYLACETIC ACID; 4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; 5 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,3 BENZODIOXOLE 2,2 DICARBOXYLIC ACID; [[7 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO] 5,6,7,8 TETRAHYDRO 2 NAPHTHYL]OXY]ACETIC ACID ETHYL ESTER; BETA 3 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR BLOCKING AGENT; BUPRANOLOL; CATECHOLAMINE DERIVATIVE; METOPROLOL; NADOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

DRUG RECEPTOR BINDING; HEART FAILURE; HEART MUSCLE; HEART MUSCLE CONTRACTILITY; HUMAN; INOTROPISM; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE CONTRACTILITY; VASODILATATION; ANIMAL; BIOSYNTHESIS; CARDIOVASCULAR FUNCTION; DRUG ANTAGONISM; DRUG EFFECT; PHYSIOLOGY;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CARDIOVASCULAR PHYSIOLOGY; HUMANS; RECEPTORS, ADRENERGIC, BETA-3;

EID: 0034310732     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(00)01562-5     Document Type: Review

References (68)

1. 3 and atypical β-adrenoceptors
2. 3-adrenoceptor: the search for a physiological function
3. 3-adrenoceptor expression in white fat cells
4. 3-adrenergic receptor
5. 3-adrenergic receptor
6. 3-adrenergic receptors expressed in native fat cells and in transfected cell lines
7. 3-adrenergic receptor cDNA
8. 3-adrenoceptors with low lipolytic action in human subcutaneous white adipocytes
9. 3-adrenergic receptors under the control of human gene regulatory elements
10. 3-adrenergic receptor mRNA in man
11. 3-adrenoceptor mRNA in human tissues
12. 3-adrenoceptor mRNA in rat tissues
13. 3-adrenoceptor in the human heart
14. 3H]SB206606
15. 3-adrenergic receptor
16. 3-adrenoceptor in human adipose tissue, atrium and skeletal muscle
17. 3-adrenoceptor and its Gi-protein
18. 3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle
19. Modulation of human cardiac function through 4 β-adrenoceptor populations
20. 3-adrenergic regulation of the L-type calcium current in human atrial myocytes
21. Four β-adrenoceptor subtypes in the mammalian heart
22. On the presence of a putative fourth β-adrenoceptor in human adipose tissue
23. 3-adrenoceptor knockout mice
24. 3-adrenergic-independent effects of CGP12177 in brown adipose tissue
25. 3-adrenoceptor in the rat
26. 3 receptors and rat atrial receptors mediating tachycardia
27. 3-adrenoceptor agonists
28. 3-adrenergic receptors in the canine myocardium
29. 3-adrenoceptor stimulation in the beating guinea pig heart
30. 3-adrenoceptors but baroreflex mechanisms
31. 3-adrenergic receptor stimulation in conscious dogs
32. 3-adrenergic receptor cardiovascular regulation in conscious primates, rats and dogs
33. 3-adrenoceptors in man
34. 3-adrenoceptor agonist BRL35135 in man
35. 3-adrenoceptor-mediated increase in cutaneous blood flow in the dog
36. 3-adrenergic agonist, BRL26830A, and a/b blocker, arotinolol, markedly increase regional blood flow in the brown adipose tissue in anesthetized rats
37. 3-adrenoceptor agonist induces increased pancreatic islet blood flow and insulin secretion in rats
38. 2-adrenergic receptors
39. Atypical β-adrenoceptors in the rat isolated common carotid artery
40. 3-adrenoceptor stimulation induces vasorelaxation mediated essentially by endothelium-derived nitric oxide in rat thoracic aorta
41. Different atypical β-adrenoceptors mediate isoprenaline-induced relaxation in vascular and non-vascular smooth muscles
42. 3-adrenoceptors) mediating relaxation in the rat distal colon in vitro
43. 3-adrenoceptor
44. 2- and atypical β-adrenoceptor-mediated relaxation in rat isolated aorta
45. Regulation of cardiac β-adrenergic response by nitric oxide
46. 3-adrenoceptor control the cystic fibrosis transmembrane conductance regulator through a cAMP/protein kinase A-independent pathway
47. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA
48. 3-adrenoreceptors regulate CFTR conductance through a PTX-sensitive G protein
49. 3-adrenoceptors to the KvLQT1/minK potassium channel
50. 2+ channels in rat portal vein myocytes
51. Atypical adrenoceptor-mediated relaxation of canine pulmonary artery through a cAMP-dependent pathway
52. 3-adrenoceptor antagonist SR59230A
53. β-adrenergic receptor blockade arrests myocyte damage and preserves cardiac function in the transgenic G(sa) mouse
54. Adverse effects of chronic endogenous sympathetic drive induced by cardiac Gsa overexpression
55. 1-adrenergic receptor transgenic mice
56. 2-adrenergic receptor overexpression in mouse hearts
57. 2-adrenergic receptors differentially affect cardiac hypertrophy and function in Gaq-overexpressing mice
58. 2-adrenergic receptor to different G proteins by protein kinase A
59. Adrenergic and muscarinic receptors in the human heart
60. Endomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathy
61. Nitric oxide modulates mitochondrial respiration in failing human heart
62. 3-adrenoceptor polymorphism with obesity and diabetes: current status
63. 3 adrenergic receptor with body mass index
64. 3-adrenergic receptor in essential hypertension, insulin resistance and the adrenergic system
65. 3-adrenergic-receptor gene polymorphism with essential hypertension in the Sardinian population
66. β-adrenergic receptor blockade in chronic heart failure
67. 3-adrenergic receptor antagonists
68. G protein regulation of adenylate cyclase